{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:33Z","timestamp":1786979793967,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00216-026-06556-5","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:16:08Z","timestamp":1778775368000},"page":"4599-4612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LC\u2013HRMS detection of three ionizable lipids in equine plasma: surrogate markers for long-term LNP-mediated gene-doping surveillance"],"prefix":"10.1007","volume":"418","author":[{"given":"Yoshibumi","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Sugai-Bannai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Hirano-Kodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Tozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Ngai-Wa","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"6556_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114990","volume":"200","author":"M Jeong","year":"2023","unstructured":"Jeong M, Lee Y, Park J, Jung H, Lee H. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Adv Drug Deliv Rev. 2023;200:114990. https:\/\/doi.org\/10.1016\/j.addr.2023.114990.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"6556_CR2","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","volume":"17","author":"S Patel","year":"2017","unstructured":"Patel S, Ashwanikumar N, Robinson E, DuRoss A, Sun C, Murphy-Benenato KE, et al. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Lett. 2017;17(9):5711\u20138. https:\/\/doi.org\/10.1021\/acs.nanolett.7b02664.","journal-title":"Nano Lett"},{"issue":"7","key":"6556_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25(7):1467\u201375. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.013.","journal-title":"Mol Ther"},{"key":"6556_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O, et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol Ther Nucleic Acids. 2019;15:1\u201311. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.013.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"6556_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","volume":"34","author":"R Tenchov","year":"2023","unstructured":"Tenchov R, Sasso JM, Zhou QA. PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective. Bioconjug Chem. 2023;34(6):941\u201360. https:\/\/doi.org\/10.1021\/acs.bioconjchem.3c00174.","journal-title":"Bioconjug Chem"},{"issue":"Pt A","key":"6556_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.09.012.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"6556_CR7","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1529\/biophysj.106.083766","volume":"91","author":"BG Tenchov","year":"2006","unstructured":"Tenchov BG, MacDonald RC, Siegel DP. Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane \u201cfusogen.\u201d Biophys J. 2006;91(7):2508\u201316.","journal-title":"Biophys J"},{"issue":"8","key":"6556_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202106727","volume":"32","author":"M Cornebise","year":"2022","unstructured":"Cornebise M, Narayanan E, Xia Y, Acosta E, Ci L, Koch H, et al. Discovery of a novel amino lipid that improves lipid nanoparticle performance through specific interactions with mRNA. Adv Funct Mater. 2022;32(8):2106727.","journal-title":"Adv Funct Mater"},{"issue":"15","key":"6556_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202209624","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam K, Leung A, Martin A, Wood M, Schreiner P, Palmer L, et al. Unsaturated, trialkyl ionizable lipids are versatile lipid-nanoparticle components for therapeutic and vaccine applications. Adv Mater. 2023;35(15):e2209624. https:\/\/doi.org\/10.1002\/adma.202209624.","journal-title":"Adv Mater"},{"issue":"1","key":"6556_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han X, Zhang H, Butowska K, Swingle KL, Alameh MG, Weissman D, et al. An ionizable lipid toolbox for RNA delivery. Nat Commun. 2021;12(1):7233. https:\/\/doi.org\/10.1038\/s41467-021-27493-0.","journal-title":"Nat Commun"},{"issue":"34","key":"6556_CR11","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl. 2012;51(34):8529\u201333. https:\/\/doi.org\/10.1002\/anie.201203263.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"6556_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcph.1553","volume":"60","author":"X Zhang","year":"2020","unstructured":"Zhang X, Goel V, Robbie GJ. Pharmacokinetics of patisiran, the first approved RNA interference therapy in patients with hereditary transthyretin-mediated amyloidosis. J Clin Pharmacol. 2020;60(5):573\u201385. https:\/\/doi.org\/10.1002\/jcph.1553.","journal-title":"J Clin Pharmacol"},{"issue":"15","key":"6556_CR13","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","volume":"78","author":"SM Hoy","year":"2018","unstructured":"Hoy SM. Patisiran: first global approval. Drugs. 2018;78(15):1625\u201331. https:\/\/doi.org\/10.1007\/s40265-018-0983-6.","journal-title":"Drugs"},{"key":"6556_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2021.100424","volume":"41","author":"Y Suzuki","year":"2021","unstructured":"Suzuki Y, Ishihara H. Difference in the lipid nanoparticle technology employed in three approved siRNA (patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021;41:100424. https:\/\/doi.org\/10.1016\/j.dmpk.2021.100424.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"11","key":"6556_CR15","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles\u2014 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"issue":"3-4","key":"6556_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41434-021-00267-5","volume":"29","author":"T Tozaki","year":"2022","unstructured":"Tozaki T, Hamilton NA. Control of gene doping in human and horse sports. Gene Ther. 2022;29(3\u20134):107\u201312. https:\/\/doi.org\/10.1038\/s41434-021-00267-5.","journal-title":"Gene Ther"},{"issue":"12","key":"6556_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/dta.3664","volume":"16","author":"R Li","year":"2024","unstructured":"Li R, Su P, Shi Y, Shi H, Ding S, Su X, et al. Gene doping detection in the era of genomics. Drug Test Anal. 2024;16(12):1468\u201378. https:\/\/doi.org\/10.1002\/dta.3664.","journal-title":"Drug Test Anal"},{"key":"6556_CR18","unstructured":"IFHA, International Agreement on Breeding and Racing and Appendixes: Article 6B (RACING) Prohibition of genetic therapy, gene editing and genome editing, January 2020 https:\/\/www.ifhaonline.org\/default.asp?section=IABRW&area=2#article6e. Accessed 25 Dec 2025."},{"key":"6556_CR19","unstructured":"WORLD ANTI-DOPING CODE, INTERNATIONAL STANDARD, PROHIBITED LIST, 1 January 2026 https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-09\/2026list_en_final_clean_september_2025.pdf. Accessed 25 Dec 2025."},{"issue":"3","key":"6556_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/genes10030243","volume":"10","author":"T Tozaki","year":"2019","unstructured":"Tozaki T, Ohnuma A, Takasu M, Kikuchi M, Kakoi H, Hirota KI, et al. Droplet digital PCR detection of the erythropoietin transgene from horse plasma and urine for gene-doping control. Genes Basel. 2019;10(3):243. https:\/\/doi.org\/10.3390\/genes10030243.","journal-title":"Genes Basel"},{"issue":"1","key":"6556_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/acs.analchem.5c05862","volume":"98","author":"R Furukawa","year":"2026","unstructured":"Furukawa R, Shinoda H, Tozaki T, Makino A, Yoshimura M, Iida T, et al. Direct single-molecule detection of mRNA-LNP drugs in blood. Anal Chem. 2026;98(1):756\u201365. https:\/\/doi.org\/10.1021\/acs.analchem.5c05862.","journal-title":"Anal Chem"},{"issue":"6","key":"6556_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41434-025-00569-y","volume":"32","author":"D Wu","year":"2025","unstructured":"Wu D, Ding S, Liu N, Shi Y, Su P, Shi H, et al. Codon changes challenge PCR-based gene doping detection. Gene Ther. 2025;32(6):632\u201340. https:\/\/doi.org\/10.1038\/s41434-025-00569-y.","journal-title":"Gene Ther"},{"issue":"18","key":"6556_CR23","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.1021\/acs.analchem.1c01173","volume":"93","author":"T Tozaki","year":"2021","unstructured":"Tozaki T, Ohnuma A, Iwai S, Kikuchi M, Ishige T, Kakoi H, et al. Robustness of digital PCR and real-time PCR in transgene detection for gene-doping control. Anal Chem. 2021;93(18):7133\u20139.","journal-title":"Anal Chem"},{"issue":"8","key":"6556_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911\u20137. https:\/\/doi.org\/10.1139\/o59-099.","journal-title":"Can J Biochem Physiol"},{"issue":"1","key":"6556_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Stanley GS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497\u2013509.","journal-title":"J Biol Chem"},{"key":"6556_CR26","unstructured":"AORC guidelines for the minimum criteria for identification by chromatography and mass spectrometry, 22 March 2024 https:\/\/www.aorc-online.org\/documents\/aorc-ms-criteria-ilacg7\/. Accessed 30 Oct 2025."},{"issue":"1","key":"6556_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev.anchem.111808.073705","volume":"3","author":"SJ Blanksby","year":"2010","unstructured":"Blanksby SJ, Mitchell TW. Advances in mass spectrometry for lipidomics. Annu Rev Anal Chem. 2010;3(1):433\u201365.","journal-title":"Annu Rev Anal Chem"},{"issue":"4","key":"6556_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7150\/ijms.6.168","volume":"6","author":"A Tokumura","year":"2009","unstructured":"Tokumura A, Carbone LD, Yoshioka Y, Morishige J, Kikuchi M, Postlethwaite A, et al. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. Int J Med Sci. 2009;6(4):168\u201376. https:\/\/doi.org\/10.7150\/ijms.6.168.","journal-title":"Int J Med Sci"},{"issue":"47","key":"6556_CR29","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1039\/d4ay01477d","volume":"16","author":"K Ohnuma","year":"2024","unstructured":"Ohnuma K, Hirano-Kodaira M, Bannai M, Shimizu Y, Yamada M, Kinoshita K, et al. A broad-spectrum peptide screening method using an optimized solid-phase extraction and liquid chromatography-high-field asymmetric ion mobility spectrometry-mass spectrometry for doping control in equine urine. Anal Methods. 2024;16(47):8250\u201367. https:\/\/doi.org\/10.1039\/d4ay01477d.","journal-title":"Anal Methods"},{"key":"6556_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2024.101628","volume":"80","author":"Y Shimizu","year":"2025","unstructured":"Shimizu Y, Sugai-Bannai M, Saito K, Hirano-Kodaira M, Leung GN. Identification and differentiation of somapacitan, a long-acting growth hormone derivative, and recombinant human growth hormone in equine plasma by LC-HRMS for doping control purpose. Growth Horm IGF Res. 2025;80:101628. https:\/\/doi.org\/10.1016\/j.ghir.2024.101628.","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"6556_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11050294","volume":"11","author":"A Apffel","year":"2021","unstructured":"Apffel A, Zhao L, Sartain MJ. A novel solid phase extraction sample preparation method for lipidomic analysis of human plasma using liquid chromatography\/mass spectrometry. Metabolites. 2021;11(5):294. https:\/\/doi.org\/10.3390\/metabo11050294.","journal-title":"Metabolites"},{"issue":"7","key":"6556_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11095-025-03890-8","volume":"42","author":"Z-R Lu","year":"2025","unstructured":"Lu Z-R, Sun D. Mechanism of pH-sensitive amphiphilic endosomal escape of ionizable lipid nanoparticles for cytosolic nucleic acid delivery: Lu and Sun. Pharm Res. 2025;42(7):1065\u201377.","journal-title":"Pharm Res"},{"issue":"8","key":"6556_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2021.183627","volume":"1863","author":"K Koitabashi","year":"2021","unstructured":"Koitabashi K, Nagumo H, Nakao M, Machida T, Yoshida K, Sakai-Kato K. Acidic pH-induced changes in lipid nanoparticle membrane packing. Biochim Biophys Acta Biomembr. 2021;1863(8):183627. https:\/\/doi.org\/10.1016\/j.bbamem.2021.183627.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"6556_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113945","volume":"384","author":"Y Ren","year":"2025","unstructured":"Ren Y, Lin L, Abdallah M, Zhu X, Liu H, Fabb SA, et al. Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection. J Control Release. 2025;384:113945. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113945.","journal-title":"J Control Release"},{"issue":"1","key":"6556_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/dta.1939","volume":"9","author":"S Esposito","year":"2017","unstructured":"Esposito S, Colicchia S, de la Torre X, Mazzarino M, Botre F. Liposomes as potential masking agents in sport doping. Part 1: analysis of phospholipids and sphingomyelins in drugs and biological fluids by aqueous normal-phase liquid chromatography-tandem mass spectrometry. Drug Test Anal. 2017;9(1):75\u201386. https:\/\/doi.org\/10.1002\/dta.1939.","journal-title":"Drug Test Anal"},{"issue":"1\u20132","key":"6556_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0169-409x(01)00154-5","volume":"50","author":"C Oussoren","year":"2001","unstructured":"Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 2001;50(1\u20132):143\u201356. https:\/\/doi.org\/10.1016\/s0169-409x(01)00154-5.","journal-title":"Adv Drug Deliv Rev"},{"issue":"41","key":"6556_CR37","doi-asserted-by":"publisher","first-page":"12758","DOI":"10.1021\/acs.nanolett.4c02566","volume":"24","author":"K Hashiba","year":"2024","unstructured":"Hashiba K, Taguchi M, Sakamoto S, Otsu A, Maeda Y, Suzuki Y, et al. Impact of lipid tail length on the organ selectivity of mRNA-lipid nanoparticles. Nano Lett. 2024;24(41):12758\u201367. https:\/\/doi.org\/10.1021\/acs.nanolett.4c02566.","journal-title":"Nano Lett"},{"issue":"12","key":"6556_CR38","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41591-021-01573-6","volume":"27","author":"A August","year":"2021","unstructured":"August A, Attarwala HZ, Himansu S, Kalidindi S, Lu S, Pajon R, et al. A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med. 2021;27(12):2224\u201333. https:\/\/doi.org\/10.1038\/s41591-021-01573-6.","journal-title":"Nat Med"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06556-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:55:43Z","timestamp":1784184943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06556-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":38,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6556"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06556-5","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The administration protocols were approved by the Animal Care and Use Committees of the Japan Racing Association (JRA) Equine Research Institute (Review no. 25-9) and the Laboratory of Racing Chemistry (Review no. 20-4). All experiments were performed in accordance with the relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}